AbbVie Maintains Xeljanz Safety Concerns Don’t Spill Over To Rinvoq

 
• By Joseph Haas
4th quarter computer key on key board
AbbVie's Q4 revenues came in strong despite some pandemic impact on the cancer franchise

More from Earnings

More from Business